natgillin/translations-raw huggingface dataset:
Suspensionen skal anvendes indenfor 21 dage efter at cylinderampullen er monteret i en pen.
After insertion of the cartridge in a pen, the suspension should be used in 21 days when stored below 30°C.
5 x 3 ml Humalog BASAL cylinderampuller til brug i en 3 ml pen 2 x (5 x 3 ml) Humalog BASAL cylinderampuller til brug i en 3 ml pen
5 x 3 ml Humalog BASAL cartridges for a 3 ml pen 2 x (5 x 3 ml) Humalog BASAL cartridges for a 3 ml pen
Instruktioner vedrørende anvendelse og håndtering Humalog BASAL cylinderampuller er beregnet til at blive brugt sammen med en CE mærket pen, som anbefalet i brugsanvisningen fra fremstilleren af pennen.
Instructions for use and handling Humalog BASAL cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
Cartridges containing Humalog BASAL should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
Humalog BASAL cylinderampuller er udformet således, at andet insulin ikke kan blandes i ampullen.
Humalog BASAL cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Følgende instruktion er generel.
50 The following is a general description.
50 1.
1.
Humalog Pen 100 E/ ml, injektionsvæske, opløsning
Humalog Pen 100 U/ ml, solution for injection
Humalog Pen er en steril, klar, farveløs, vandig opløsning.
Humalog Pen is a sterile, clear, colourless, aqueous solution.
Humalog Pen er også indiceret til initial stabilisering af diabetes mellitus.
Humalog Pen is also indicated for the initial stabilisation of diabetes mellitus.
Ved subkutan injektion af Humalog Pen skal man være påpasselig med ikke at injicere direkte i et blodkar.
When administered subcutaneously care should be taken when injecting Humalog Pen to ensure that a blood vessel has not been entered.
Humalog Pen har en hurtigt indsættende virkning og en kortere virkningsvarighed (2- 5 timer), ved subkutan injektion, end opløselig insulin.
Humalog Pen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.
Som med alle insulinpræparater afhænger virkningsvarigheden af Humalog Pen af dosis, indstikssted, blodtilførsel, temperatur og fysisk aktivitet.
As with all insulin preparations, the duration of action of Humalog Pen is dependent on dose, site of injection, blood supply, temperature, and physical activity.
52 Brug af Humalog i en insulin infusionspumpe Kun visse CE- mærkede insulininfusionspumper kan anvendes til infusion af insulin lispro.
Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro.
Hos patienter med kronisk leverfunktionsnedsættelse kan øget insulinresistens imidlertid medføre et øget insulinbehov.
Insulin requirements may be reduced in patients with hepatic impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown; however, in patients with chronic hepatic impairment, an increase in insulin resistance may lead to increased insulin requirements
53 Justering af insulindosis kan også være nødvendig, hvis patienterne øger den daglige fysiske aktivitet eller ved kostændringer.
53 Adjustment of dosage may also be necessary if patients undertake increased physical activity or change their usual diet.
Insulinbehovet kan være nedsat under samtidig behandling med lægemidler med hypoglykæmisk aktivitet, f. eks. orale antidiabetika, salicylater (f. eks. acetylsalicylsyre), sulfapræparater, visse antidepressiva (monoaminooxidasehæmmere), visse angiotensin konverteringsenzym (ACE) hæmmere (captopril, enalapril), angiotensin II- receptorblokkere, beta- blokkere, octreotid eller alkohol.
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
Lægen bør konsulteres, når der tages anden medicin samtidig med Humalog Pen.
The physician should be consulted when using other medications in addition to Humalog Pen.
Systemisk allergi, som er sjælden (≥1/ 10. 000 til < 1/ 1. 000), men potentielt mere alvorlig, er en generaliseret overfølsomhed overfor insulin.
It may cause a rash over the whole
Denne kan 54 give udslæt over hele kroppen, åndenød, hvæsende vejrtrækning, blodtryksfald, hurtig puls eller svedtendens.
54 body, shortness of breath, wheezing, reduction in blood pressure, fast pulse, or sweating.
ATC- kode:
Fast-acting human insulin analogue, ATC code:
55 Insulin lispro Humulin Regular Hypoglykæmisk aktivitet
2
De ovenfor anførte kurver illustrerer den relative mængde glukose, som over tid er nødvendig for at opretholde blodglukose koncentrationer nær fasteniveau og viser samtidig den tidsrelaterede effekt af disse insuliner på glukosemetabolismen.
Time (Hours) The above representation reflects the relative amount of glucose over time required to maintain the subject's whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time.
Den
In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function.
56 hurtigere absorption og elimination af insulin lispro sammenlignet med opløselig human insulin opretholdes hos patienter med nedsat leverfunktion.
Insulin lispro maintains more rapid 56 absorption and elimination when compared to soluble human insulin in patients with hepatic impairment.
Pennen skal i denne periode opbevares ved højst 30°C.
After first use of the pen, the solution should be used within 28 days, when stored below 30°C.
Væsken opbevares i Type 1 flintglas cylinderampuller, forseglede med butyl eller halobutyl gummimembraner og stempler og sikrede med aluminiumforseglinger.
The solution is contained in type I flint glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads and are secured with aluminium seals.
Dimeticon eller silikone emulsion kan være brugt til behandling af stemplerne og/ eller cylinderampullerne.
Dimeticone or silicone emulsion may be used to treat the cartridge plunger, and/ or the glass cartridge.
5 x 3 ml penne 2 x (5 x 3 ml) penne.
5 x 3 ml Pens 2 x (5 x 3 ml) Pens
57 Instruktioner vedrørende anvendelse og håndtering a) Klargøring
57 a) Preparing a dose
Kontroller Humalog Pen- opløsningen.
Inspect the Humalog Pen solution.
Brug ikke Humalog Pen, hvis insulinet virker uklart, tyktflydende, er let farvet, eller hvis der ses småpartikler i væsken.
Do not use Humalog Pen if it appears cloudy, thickened, or slightly coloured or if solid particles are visible.
Påsæt nålen.
Put on the needle.
Tør gummimembranen af med en desinfektionsserviet.
Wipe the rubber seal with alcohol.
Fjern papirforseglingen fra nålen.
Remove the paper tab from the capped needle.
Skru nålen med nålehætte fast på pennen i urets retning.
Screw the capped needle clockwise onto the pen until it is tight.
Hold pennen lodret med nålen opad og fjern den ydre og indre nålehætte.
Hold the pen with needle pointing up and remove the outer needle cap and inner needle cover.
Kontroller insulinflowet
Priming the Pen (check Insulin Flow).
(a) Pilen skal kunne ses i doseringsvinduet.
(a) The arrow should be visible in the dose window.
Hvis pilen ikke er synlig, skal doseringsknappen drejes med uret, indtil pilen kommer til syne, og de to tapper er ud for hinanden.
If the arrow is not present, turn the dose knob clockwise until the arrow appears and notch is felt or visually aligned.
(b) Træk doseringsknappen ud (i pilens retning), indtil "0" kommer til syne i doseringsvinduet.
(b) Pull dose knob out (in direction of the arrow) until a “ 0” appears in the dose window.
En dosis kan ikke indstilles, før doseringsknappen er trukket ud.
A dose cannot be dialled until the dose knob is pulled out.
(c) Drej doseringsknappen med uret, indtil "2" kommer til syne i doseringsvinduet.
(c) Turn dose knob clockwise until a “ 2” appears in the dose window.
Bank let med en finger på den gennemsigtige beholder, således at eventuelle luftbobler samles i toppen.
(d) Hold the pen with needle pointing up and tap the clear cartridge holder gently with your finger so any air bubbles collect near the top.
Tryk injektionsknappen helt ind, indtil der mærkes eller høres et klik.
Depress the injection button fully until you feel or hear a click.
En dråbe insulin bør komme til syne på spidsen af nålen.
You should see a drop of insulin at the tip of the needle.
Hvis insulindråben ikke viser sig, skal denne procedure gentages, indtil insulindråben kommer til syne.
If insulin does not appear, repeat the procedure until insulin appears.
(e) Kontroller altid insulinflowet før hver injektion.
(e) Always prime the pen (check the insulin flow) before each injection.
Hvis insulinflowet ikke kontrolleres, kan dette medføre en unøjagtig dosis.
Failure to prime the pen may result in an inaccurate dose.
Indstilling af dosis
Setting the Dose.
(a) Drej doseringsknappen med uret, indtil pilen kommer til syne i doseringsvinduet, og de to tapper er ud for hinanden.
(a) Turn the dose knob clockwise until the arrow appears in the dose window and a notch is felt or visually aligned.
(b) Træk doseringsknappen ud (i pilens retning), indtil "0" kommer til syne i doseringsvinduet.
(b) Pull the dose knob out (in the direction of the arrow) until a “ 0” appears in the dose window.
(c) Drej doseringsknappen med uret, indtil den ønskede dosis kommer til syne i doseringsvinduet.
(c) Turn the dose knob clockwise until the dose appears in the dose window.
Hvis der indstilles en for stor dosis, kan doseringsknappen drejes tilbage (mod uret), indtil den korrekte dosis kan ses i doseringsvinduet.
If too high a dose is dialled, turn the dose knob backward (anti-clockwise) until the correct dose appears in the window.
Man kan ikke indstille en dosis, der er større end det antal enheder, der er tilbage i cylinderampullen.
A dose greater than the number of units remaining in the cartridge cannot be dialed.
b) Injektion
(b) Injecting a dose
58 5.
5.
Vent 5 sekunder.
Press the injection button down with the thumb (until you hear or feel a click); wait 5 seconds.
Skru nålen af umiddelbart efter injektionen ved hjælp af nålens ydre hætte.
Immediately after an injection, use the outer needle cap to unscrew the needle.
Fjern nålen fra pennen.
Remove the needle from the pen.
Dette sikrer sterilitet og forhindrer lækage, indtrængen af luft og mulig tilstopning af nålen.
This will ensure sterility, and prevent leakage, reentry of air, and potential needle clogs.
Genbrug ikke nålen.
Do not reuse the needle.
Kassér nålen på sikker og forsvarlig vis.
Dispose of the needle in a responsible manner.
Nåle og penne må ikke deles med andre.
Needles and pens must not be shared.
Den præfyldte pen kan bruges, indtil den er tom.
The prefilled pen can be used until it is empty.
Derefter kasseres den på passende vis, eller materialerne genanvendes.
Please properly discard or recycle.
Injektionsknappen skal være trykket helt ind, før pennen bruges igen.
The injection button should be fully depressed before using the pen again.
c) Blanding af insuliner
(c) Mixing insulins
EU/ 1/ 96/ 007/ 015 5 x 3 ml penne EU/ 1/ 96/ 007/ 026 2 x (5 x 3 ml) penne
EU/ 1/ 96/ 007/ 015 EU/ 1/ 96/ 007/ 026
Humalog Mix25 100 E/ ml Pen injektionsvæske, suspension
Humalog Mix25 100 U/ ml Pen, suspension for injection
60 Hypoglykæmi.
60 Hypoglycaemia.
61 Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
61 It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
Glukose skal dog gives intravenøst, hvis glukagon ikke er tilgængeligt, eller hvis patienten ikke responderer på glukagon.
However, glucose solution must be given intravenously if glucagon is not available or if the patient
62 Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
The patient should be given a meal as soon as consciousness is recovered.
Humalog Mix25 er en færdigblandet suspension af insulin lispro (hurtigt virkende human insulin- analog) og insulin lispro protaminsuspension (middelhurtigt virkende human insulin- analog).
Humalog Mix25 is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue).
Humalog Mix25 Humalog Mix25 NPL Humalog Basal
Hypoglycaemic activity Humalog Mix25 Humalog Basal
De ovenfor anførte kurver illustrerer den relative mængde glukose, som over tid er nødvendig for at opretholde blodglukose- koncentrationer nær fasteniveau, og viser samtidig den tidsrelaterede effekt af disse insuliner på glukosemetabolismen.
63 The above representation reflects the relative amount of glucose over time required to maintain the subject's whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time.
63 Det er vist, at insulin lispro på molekylært niveau er lige så potent som human insulin, men dets effekt er hurtigere og af kortere varighed.
Insulin lispro has been shown to be equipotent to human insulin on a molar basis but its effect is more rapid and of a shorter duration.
(gns. ved baseline = 8. 7%) (gns. ved baseline = 8. 5%) Reduktion af gennemsnittet af morgen og
(mean at baseline = 8.5%)
1
Reduction of the mean of combined morning / evening two-hour postprandial 1 blood glucose
aften to- timers postprandial blodglucose Reduktion af blodglucose
Reduction of the mean fasting blood 1 glucose
hypoglykæmi ved
Incidence of hypoglycaemia at endpoint Bodyweight gain2
Pennen skal i denne periode opbevares ved højst 30°C.
After first use of the pen, the suspension should be used within 28 days, when stored below 30°C.
Suspensionen opbevares i Type 1 flintglas cylinderampuller, forseglede med halobutyl gummimembraner og stempelhoveder og sikrede med aluminiumforseglinger.
The suspension is contained in type I flint glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals.
3 ml cylinderampullerne er indbyggede i éngangspenne, som kaldes “ Pen ”.
The 3 ml cartridges are sealed in a disposable pen injector, called the “ Pen”.
5 x 3 ml Humalog Mix25 100 E/ ml Pen 2 x (5 x 3 ml) Humalog Mix25 100 E/ ml Pen
2 x (5 x 3 ml) Humalog Mix25 100 U/ ml Pens.
Instruktioner vedrørende anvendelse og håndtering a) Klargøring
Instructions for use and handling a) Preparing a dose
Kontroller Humalog Mix25 Pen.
Inspect the Humalog Mix25 100 U/ ml Pen.
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
The Pen should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
65 Cylinderampullerne bør kontrolleres jævnligt og bør ikke bruges, hvis de indeholder klumper, eller hvis faste hvide partikler, der ligner rimfrost, har sat sig fast på bunden eller på siden af ampullen.
65 The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving a frosted appearance.
Kontroller insulinflowet
Priming Pen (check insulin flow).
Man kan ikke indstille en dosis, der er større end det antal enheder, der er tilbage i cylinderampullen.
A dose greater than the number of units remaining in the cartridge cannot be dialled.
(b) Injektion
(b) Injecting a dose
Tryk injektionsknappen ind med tommelfingeren, indtil der høres eller mærkes et klik.
Press the injection button down with the thumb (until you hear or feel a click); wait 5 seconds.
Vent 5 sekunder.
Do not rub the area.
66 7.
66 8.
Dette sikrer sterilitet og forhindrer lækage, indtrængen af luft og mulig tilstopning af nålen.
This will ensure sterility, and prevent leakage, re-entry of air, and potential needle clogs.
Den præfyldte pen kan bruges, indtil den er tom.
The pre-filled pen can be used until it is empty.
EU/ 1/ 96/ 007/ 016 5 x 3 ml Humalog Mix25 100 E/ ml Penne EU/ 1/ 96/ 007/ 027 2 x (5 x 3 ml) Humalog Mix25 100 E/ ml Penne
EU/ 1/ 96/ 007/ 016 EU/ 1/ 96/ 007/ 027
Humalog Mix50 100 E/ ml Pen injektionsvæske, suspension
Humalog Mix50 100 U/ ml Pen, suspension for injection
Virkningsvarigheden af insulin lispro protaminsuspension (BASAL) - delen af Humalog Mix50 svarer til virkningsvarigheden af basal insulin (isophan).
The duration of action of the insulin lispro protamine suspension (BASAL) component of Humalog Mix50 is similar to that of a basal insulin NPH.
68 Hypoglykæmi.
68 Hypoglycaemia.
Insulinbehovet kan være nedsat under samtidig behandling med lægemidler med hypoglykæmisk aktivitet, f. eks. orale antidiabetika, salicylater (f. eks. acetylsalicylsyre), sulfapræparater, visse antidepressiva (monoaminooxidasehæmmere), visse angiotensin konverteringsenzym (ACE) hæmmere (captopril, enalapril), angiotensin II receotor blokkere, beta- blokkere, octreotid eller alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
69 Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
69 It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
70 Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
The patient should be given a meal as soon as consciousness is recovered.
Humalog Mix50 er en færdigblandet suspension af insulin lispro (hurtigt virkende human insulin- analog) og insulin lispro protaminsuspension (middelhurtigt virkende human insulin- analog).
Humalog Mix50 is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue).
Humalog Mix50 Humalog Mix50 NPL Humalog Basal
Humalog Mix50 Humalog Basal
Hypoglykæmis k aktivitet
Hypoglycaemic activity
Det glukodynamiske respons på insulin lispro påvirkes ikke af nedsat nyre - eller leverfunktion.
71 The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment.
71 Farmakokinetikken af insulin lispro afspejler hurtig absorption og opnåelse af maksimal plasmakoncentration 30 - 70 minutter efter subkutan injektion.
The pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed, and achieves peak blood levels 30 to 70 minutes following subcutaneous injection.
6. 4 Særlige opbevaringsforhold
72 6.4 Special precautions for storage
72 Suspensionen opbevares i Type 1 flintglas cylinderampuller, forseglede med halobutyl gummimembraner og stempelhoveder og sikrede med aluminiumforseglinger.
The suspension is contained in type I flint glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals.
5 x 3 ml Humalog Mix50 100 E/ ml Pen 2 x (5 x 3 ml) Humalog Mix50 100 E/ ml Pen.
5 x 3 ml Humalog Mix50 100 U/ ml Pens 2 x (5 x 3 ml) Humalog Mix50 100 U/ ml Pens.
Kontroller Humalog Mix50 Pen.
Inspect the Humalog Mix50 Pen.
Kontroller insulinflowet
Priming Pen (check insulin flow)
(e) Kontroller altid insulinflowet før hver injektion.
73 (e) Always prime the pen (check the insulin flow) before each injection.
73 (a) Drej doseringsknappen med uret, indtil pilen kommer til syne i doseringsvinduet, og de to tapper er ud for hinanden.
(a) Turn the dose knob clockwise until the arrow appears in the dose window and a notch is felt or visually aligned.
EU/ 1/ 96/ 007/ 017 5 x 3 ml Humalog Mix50 100 E/ ml Penne EU/ 1/ 96/ 007/ 028 2 x (5 x 3 ml) Humalog Mix50 100 E/ ml Penne
EU/ 1/ 96/ 007/ 017 EU/ 1/ 96/ 007/ 028
DATO FOR FØRSTE TILLADELSE/ FORNYELSE AF TILLADELSEN
5 x 3 ml Humalog Mix50 100 U/ ml Pens 2 x (5 x 3 ml) Humalog Mix50 100 U/ ml Pens
74 Dato for første markedsføringstilladelse:
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION
75 1.
75 1.
Humalog BASAL 100 E/ ml Pen injektionsvæske, suspension
Humalog BASAL 100 U/ ml Pen, suspension for injection
Humalog BASAL bør under ingen omstændigheder gives intravenøst.
4.4 Special warnings and precautions for use 76 Under no circumstances should Humalog BASAL be given intravenously.
Lægen bør konsulteres, når der tages anden medicin samtidig med Humalog BASAL.
The physician should be consulted when using other medications in addition to Humalog BASAL 100 U/ ml Pen.
Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
77 It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
Diabetikere bør rådes til at oplyse deres læge om,
Patients with diabetes should be advised to inform their doctor if they are pregnant or are contemplating pregnancy.
Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
78 Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.
Når den kliniske relevans af disse kinetiske forhold overvejes, er det mere relevant at se på glukoseomsætningskurverne.
When considering the clinical relevance of these kinetics, it is more appropriate to examine the glucose utilisation curves properties.
Saltsyre og natriumhydroxid kan være tilsat for at justere pH til 7, 0- 7, 8.
Protamine sulphate m-cresol [1.76 mg/ ml] Phenol [0.80 mg/ ml] 79 Glycerol Dibasic sodium phosphate.7H2O Zinc oxide Water for injections Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0 – 7.8.
Pennen skal i denne periode opbevares ved højst 30°C.
After first use of the pen, the suspension should be used within 21 days, when stored below 30°C.
5 x 3 ml Humalog BASAL 100 E/ ml Pen 2 x (5 x 3 ml) Humalog BASAL 100 E/ ml Pen
5 x 3 ml Humalog BASAL 100 U/ ml Pens 2 x (5 x 3 ml) Humalog BASAL 100 U/ ml Pens
Kontroller Humalog BASAL Pen.
Inspect the Humalog BASAL 100 U/ ml Pen.
Pennen bør rulles mellem håndfladerne ti gange og vendes op og ned ti gange umiddelbart før brug for at opblande insulinet.
The Pen should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
If not, repeat the above procedure until contents are mixed.
Hvis dette ikke er tilfældet, gentages ovennævnte procedure, indtil indholdet er blandet.
Cartridges contain a small glass bead to assist mixing.
80 3.
80 3.
Gnid ikke på hudområdet.
Pull the needle out and apply gentle pressure over the injection site for several seconds. Do not rub the area.
81 Den præfyldte pen kan bruges, indtil den er tom.
The pre-filled pen can be used until it is empty.
(c) Blanding af insuliner
(c) Mixing insulins
EU/ 1/ 96/ 007/ 018 EU/ 1/ 96/ 007/ 030
EU/ 1/ 96/ 007/ 018 EU/ 1/ 96/ 007/ 030
5 x 3 ml Humalog BASAL 100 E/ ml Pen 2 x (5 x 3 ml) Humalog BASAL 100 E/ ml Pen
5 x 3 ml Humalog BASAL Pen for a 3 ml pen 2 x (5 x 3 ml) Humalog BASAL Pen for a 3 ml pen
Humalog 100 E/ ml KwikPen, injektionsvæske, opløsning
Humalog 100 U/ ml KwikPen, solution for injection